NPI: 1518494244 · BARRON, WI 54812 · Multi-Specialty Clinic/Center · NPI assigned 05/12/2017
Authorized official BORTNEM, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | BORTNEM, MARK (CFO) |
| NPI Enumeration Date | 05/12/2017 |
Other providers sharing the same authorized official: BORTNEM, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,039 | $154K |
| 2019 | 6,028 | $161K |
| 2020 | 6,163 | $158K |
| 2021 | 8,861 | $200K |
| 2022 | 5,958 | $163K |
| 2023 | 5,638 | $166K |
| 2024 | 2,508 | $113K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7,740 | 6,971 | $355K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8,413 | 7,840 | $233K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,110 | 2,854 | $165K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3,470 | 3,226 | $39K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 577 | 571 | $35K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 1,131 | 1,062 | $34K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 334 | 315 | $32K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 532 | 487 | $30K |
| 99215 | Prolong outpt/office vis | 371 | 308 | $22K |
| 90834 | Psychotherapy, 45 minutes with patient | 536 | 328 | $15K |
| 87631 | 116 | 102 | $14K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 3,053 | 2,607 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,899 | 1,750 | $12K |
| 80061 | Lipid panel | 947 | 890 | $11K |
| 0002A | 272 | 264 | $10K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 169 | 168 | $10K |
| 0001A | 235 | 227 | $8K | |
| 90686 | 863 | 847 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 791 | 757 | $7K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 136 | 122 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | 874 | 814 | $6K |
| 80053 | Comprehensive metabolic panel | 672 | 619 | $6K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 376 | 174 | $5K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 377 | 333 | $5K |
| 99233 | Prolong inpt eval add15 m | 295 | 147 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 141 | 131 | $3K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 424 | 188 | $3K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 191 | 171 | $2K |
| 0004A | 62 | 58 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | 71 | 64 | $2K |
| 90670 | 284 | 274 | $2K | |
| 99307 | 221 | 205 | $2K | |
| 0071A | 44 | 38 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 25 | 25 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 14 | 12 | $831.35 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14 | 12 | $824.20 |
| 0072A | 20 | 20 | $770.56 | |
| 71046 | Radiologic examination, chest; 2 views | 112 | 100 | $710.01 |
| 90677 | 54 | 53 | $624.72 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14 | 12 | $615.01 |
| 88142 | 29 | 29 | $578.97 | |
| 90633 | 64 | 64 | $556.30 | |
| 90698 | 182 | 171 | $545.23 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 23 | 12 | $539.97 |
| 99442 | 28 | 26 | $520.86 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 17 | 16 | $501.76 |
| 90697 | 33 | 33 | $493.98 | |
| 0031A | 13 | 13 | $465.28 | |
| 0054A | 12 | 12 | $465.28 | |
| 71045 | Radiologic examination, chest; single view | 118 | 109 | $445.42 |
| 81001 | 180 | 167 | $404.43 | |
| 90680 | 39 | 38 | $346.91 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 80 | 79 | $333.15 |
| 99222 | Initial hospital care, per day, moderate complexity | 14 | 12 | $265.50 |
| 85610 | 68 | 36 | $202.04 | |
| 92567 | 13 | 12 | $195.87 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 81 | 81 | $179.52 |
| 90656 | 12 | 12 | $152.25 | |
| 81003 | 57 | 55 | $108.88 | |
| 90685 | 31 | 29 | $97.01 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 16 | 15 | $94.43 |
| 85027 | 13 | 13 | $79.24 | |
| 99310 | Prolong nursin fac eval 15m | 15 | 15 | $75.45 |
| 82947 | 12 | 12 | $43.23 | |
| 36415 | Collection of venous blood by venipuncture | 94 | 86 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 56 | 52 | $0.00 |
| 91307 | 90 | 73 | $0.00 | |
| 91303 | 13 | 13 | $0.00 | |
| 3074F | 46 | 41 | $0.00 | |
| 91305 | 12 | 12 | $0.00 | |
| 91300 | 635 | 557 | $0.00 | |
| 3078F | 48 | 43 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 71 | 69 | $0.00 |